New flu antiviral drug may lessen length, symptoms of illness |

New flu antiviral drug may lessen length, symptoms of illness

Baloxivir, a new influenza antiviral drug, can help lessen symptoms and shorten the amount of time of the illness, researchers say.

For those who become ill with the flu, a new antiviral medication may help.

“This is really kind of a blockbuster,” says Dr. Gregory Poland, director of the Mayo Clinic Vaccine Research Group. “We have not had a new influenza antiviral drug in a couple of decades.”

“New in this last year is baloxivir, an antiviral drug that can be used to treat influenza and only takes one dose. If you develop symptoms of influenza, and you’re elderly or have medical problems, we now have a drug where we can administer one dose and treat this virus very effectively if you get in to be seen within 48 hours of developing symptoms,” says Dr. Poland.

The medication can help lessen symptoms and shorten the amount of time of the illness. It is especially important for those who are at high risk of developing complications from the flu virus, including those over age 65 and those with chronic medical problems, such as heart disease, diabetes and lung disease.

Most healthy people who become ill with the flu recover on their own and won’t need medical care or antivirals. The Centers for Disease Control and Prevention (CDC) recommends those at high risk of serious flu complications contact their health care provider for the best treatment options.

Baloxivar is one of four antiviral drugs approved by the Food and Drug Administration and recommended by the CDC. It is only licensed for those 12 and older.

Other antiviral prescription medications include oseltamivir, zanamivir and peramivir.

Who’s at risk

Those at high risk of flu complications are:

• Children younger than 5, and especially those younger than 1

• Adults older than 65

• Residents of nursing homes and other long-term care facilities

• Pregnant women and women up to two weeks postpartum

• People with weakened immune systems

• People who have chronic illnesses, such as asthma, heart disease, kidney disease, liver disease and diabetes

• People with a body mass index of 40 or higher.

Antiviral medication is not a substitute for the flu vaccine. The CDC recommends that everyone over 6 months get a flu shot annually.

Categories: News | Health Now
TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.